Chasing genes for mood disorders and schizophrenia in genetically isolated populations

被引:13
|
作者
Venken, Tine
Del-Favero, Jurgen
机构
[1] Univ Antwerp, VIB Dept Mol Genet, Appl Mol Genom Grp, B-2020 Antwerp, Belgium
[2] Univ Antwerp, B-2020 Antwerp, Belgium
关键词
complex genetics; isolated population; association studies; linkage analysis; bipolar disorder; schizophrenia;
D O I
10.1002/humu.20582
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Major affective disorders and schizophrenia are among the most common brain diseases worldwide and their predisposition is influenced by a complex interaction of genetic and environmental factors. So far, traditional linkage mapping studies for these complex disorders have not achieved the same success as the positional cloning of genes for Mendelian diseases. The struggle to identify susceptibility genes for complex disorders has stimulated the development of alternative approaches, including studies in genetically isolated populations. Since isolated populations are likely to have both a reduced number of genetic vulnerability factors and environmental background and are therefore considered to be more homogeneous compared to outbred populations, the use of isolated populations in genetic studies is expected to improve the chance of finding susceptibility loci and genes. Here we review the role of isolated populations, based on linkage and association studies, in the identification of susceptibility genes for bipolar disorder and schizophrenia. Hum Mutat 28(12), 1156-1170, 2007. (c) 2007 Wiley-Liss, Inc.
引用
收藏
页码:1156 / 1170
页数:15
相关论文
共 50 条
  • [41] INSIGHT IN SCHIZOPHRENIA AND MOOD DISORDERS AND ITS RELATION TO PSYCHOPATHOLOGY
    MICHALAKEAS, A
    SKOUTAS, C
    CHARALAMBOUS, A
    PERISTERIS, A
    MARINOS, V
    KERAMARI, E
    THEOLOGOU, A
    ACTA PSYCHIATRICA SCANDINAVICA, 1994, 90 (01) : 46 - 49
  • [42] The differences in suicidal behaviours between schizophrenia and mood disorders
    Yamaguchi, Taiju
    Fujii, Chiyo
    Saito, Junichi
    Katagiri, Naoyuki
    Tsujino, Naohisa
    Nemoto, Takahiro
    Mizuno, Masafumi
    EARLY INTERVENTION IN PSYCHIATRY, 2016, 10 : 197 - 197
  • [43] The role of atypical antipsychotics in the treatment of schizophrenia and mood disorders
    Vavrusova, L.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S140 - S141
  • [44] NEUROLOGICAL HARD SIGNS IN SCHIZOPHRENIA AND MAJOR MOOD DISORDERS
    KINNEY, DK
    YURGELUNTODD, DA
    WOODS, BT
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 1993, 181 (03) : 202 - 204
  • [45] Glutamate pyschopharmacology of schizophrenia and mood disorders: A neuroscientific dissection
    Dursun, S
    JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (05) : A7 - A7
  • [46] LONG-TERM TREATMENT OF MOOD DISORDERS IN SCHIZOPHRENIA
    AZORIN, JM
    ACTA PSYCHIATRICA SCANDINAVICA, 1995, 91 : 20 - 23
  • [47] Brain volumes in psychotic youth with schizophrenia and mood disorders
    El-Sayed, Mohamed
    Steen, R. Grant
    Poe, Michele D.
    Bethea, T. Carter
    Gerig, Guido
    Lieberman, Jeffrey
    Sikich, Linmarie
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2010, 35 (04): : 229 - 236
  • [48] COMORBIDITY OF SUBSTANCE USE DISORDER AND SCHIZOPHRENIA AND MOOD DISORDERS
    Delafariban, M.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [49] Reconstructing schizophrenia: Lessons from major mood disorders
    Tandon, Rajiv
    Greden, John F.
    SCHIZOPHRENIA RESEARCH, 2022, 242 : 42 - 44
  • [50] Psychopharmacological treatment of cognitive deficits in Schizophrenia and mood disorders
    Vita, A.
    Mussoni, C.
    Deste, G.
    Ferlenghi, G.
    Turrina, C.
    Valsecchi, P.
    JOURNAL OF PSYCHOPATHOLOGY, 2018, 24 (02): : 62 - 72